Sandeep Kalra, CEO, Persistent Systems said margins were supported by growing use of its AI platforms — SASVA, iAURA and ...
AI can accelerate drug discovery, clinical development, and patient access, but regulatory hurdles remain. Anders Romare, ...
In this series, we examine what happens after the proof of concept and how AI becomes part of the software delivery pipeline.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback